Overview

A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions

Status:
Recruiting
Trial end date:
2023-04-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics of oral administration of GC2129A in fed conditions to healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
GC Biopharma Corp
Treatments:
Metformin